Compare Cronos Group Inc (CRON) vs Crowdstrike Holdings Inc (CRWD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Crowdstrike Holdings Inc — how do they compare? Cronos Group Inc trades at $3.11 (market cap $1.14B), while Crowdstrike Holdings Inc trades at $221.94 (market cap $225.95B). The key difference: Crowdstrike Holdings Inc is far larger — about 198.2× Cronos Group Inc's market cap, and Crowdstrike Holdings Inc is trading nearer its 52-week high, Cronos Group Inc nearer its low. Which is the better fit depends on your goals.
| CRON | CRWD | |
|---|---|---|
Market Cap | $1.14B | $225.95B |
Sector | Health | Technology |
52-Week High | $3.27 | $225.16 |
52-Week Low | $2.30 | $87.56 |
Enterprise Value | $341.13M | $222.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.00, down 3.23% today, with a bullish technical signal from moving averages. The company showed strong Q2 2026 performance with 58% YoY revenue growth and earnings beat, though recent quarters were mixed. Valuation metrics include P/E of 16.21 and P/S of 6.55, while profitability improved with 45.86% gross margin. Analyst consensus is mixed with 20% buy, 60% hold ratings.
Outlook remains positive due to international expansion and strong product positioning, particularly in Canada and Europe. Key risks include competitive pressures and cash flow volatility from aggressive investing. The stock presents growth potential but requires monitoring of execution and market conditions.
CrowdStrike (CRWD) trades at $225.16, up 5.01% in the last session and near its all-time high. The stock exhibits strong technical momentum with bullish moving averages and is trading above key support at $222. Fundamentally, revenue growth remains robust, reaching $3.95 billion in 2025, though profitability is inconsistent with a net margin of -0.6%. Recent positive news includes being named a leader in IDC's MDR market assessment (Business Wire, August 11, 2026) and strong performance at industry events.
The outlook is positive given strong revenue growth and market leadership in cybersecurity, but the stock carries significant risk due to its extreme valuation multiples (P/E of 765) and intense competition. Investment appeal hinges on sustained high growth justifying the premium, while key risks include execution missteps and a broader market pullback.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Crowdstrike Holdings Inc
CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →
